These summaries provide ongoing and emerging information on BCCDC's analytical findings.

• Prevalence of risk factors for developing severe acute respiratory syndrome coronavirus 2 (COVID-19) in the Provincial Overdose Cohort (April, 2020)
  
• Prescription history and toxicology findings among people who died of an illicit drug overdose in BC, 2015-2017 (October, 2019)
  
• Demographic factors, incarceration history and risk of overdose-related death (October, 2019)
  
• Declining transport to hospital for paramedic-attended overdose events (October, 2019)
  
• Preliminary Results from the 2017 B.C Provincial Overdose Cohort Refresh (May, 2019)
  
• Update to public health stakeholders about a change to the B.C Provincial Overdose Cohort and Overdose Surveillance case definition (May 15, 2019)
  
• Analyzing prescription drug histories among people who overdose (February 15, 2018) 
  
• Analyzing patterns of health care utilization among people who overdose from illegal drugs in British Columbia (March 5, 2018)
  
• Estimated impact of the provincial take-home naloxone program on preventing illegal drug-related deaths in B.C. (March 20, 2018)
• Stratified by HSDA: Analyzing patterns of health care utilization among people who overdose from illegal drugs in B.C. (April 9, 2018)
• Leaving the emergency department without being seen or against medical advice among people who overdosed from illegal drugs in B.C. (July 16, 2018)
  
• Opioid agonist treatment (OAT) initiations post-overdose from illegal drugs in B.C. (July 30, 2018)
  
• Assessing the risk of occupational fentanyl exposures in overdose prevention services (OPS) and safe consumption services (SCS) sites in B.C. (August 2, 2018)
  
• Recent initiation, recent discontinuation and tapering patterns of prescription opioids for pain among people who experienced a drug-related overdose in B.C. (August 15, 2018)
  

• Smolina, Kate et al. "Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study." Substance Abuse (2020). DOI: 10.1080/08897077.2020.1748162.
  
• Crabtree, Alexis, et al. "Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs." Canadian Family Physician (2019): E231-E237.
  
• Irvine, Michael A., et al. "Modelling the combined impact of interventions in averting deaths during a synthetic‐opioid overdose epidemic." Addiction (2019). Related factsheet: Harm reduction.
  
• Karamouzian, Mohammad, et al. "Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program." International Journal of Drug Policy (2019).
  
• MacDougall, Laura, et al. "Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada." PLoS ONE 14.1 (2019): e0210129.
  
• Smolina, Kate, et al. "Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016." Drug and Alcohol Dependence (2018).
• Otterstatter, M. C., et al. "Patterns of health care utilization among people who overdosed from illegal drugs: a descriptive analysis using the BC Provincial Overdose Cohort." Health promotion and chronic disease prevention in Canada: research, policy and practice 38.9 (2018): 328-333.
  
• Irvine, Michael A., et al. "Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study." The Lancet Public Health 3.5 (2018): e218-e225.
• Buxton, Jane et al. "A 52-year-old man with fentanyl-induced muscle rigidity." Canadian Medical Association. Journal 190.17 (2018): E539-E541.